Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAL1308: Intensified Pediatric-Inspired ALL Treatment in Young Adults
NCT01156883Phase 2Completed
- Sponsor
- GIMEMA
- Start
- Apr 2010
- Primary completion
- Oct 2017
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of vincristine, daunorubicin, asparaginase escherichia coli, prednisone, cyclophosphamide in acute lymphoblastic leukemia (ALL), sponsored by GIMEMA. Started Apr 2010; status: completed.
02
Drugs
vincristinedaunorubicinasparaginase escherichia coliprednisonecyclophosphamide
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT01156883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01156883.